C H Koks
Overview
Explore the profile of C H Koks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koks C, Crommentuyn K, Hoetelmans R, Mathot R, Beijnen J
Ther Drug Monit
. 2001 Jul;
23(4):449-53.
PMID: 11477332
The saliva/plasma concentration ratio of fluconazole was investigated in 22 HIV-1-infected individuals with an oropharyngeal Candida infection to determine whether saliva fluconazole concentrations could provide useful information for therapeutic drug...
2.
The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals
Koks C, Crommentuyn K, Hoetelmans R, Burger D, Koopmans P, Mathot R, et al.
Br J Clin Pharmacol
. 2001 Jun;
51(6):631-5.
PMID: 11422025
Aims: To study the effect of fluconazole on the steady-state pharmacokinetics of the protease inhibitors ritonavir and saquinavir in HIV-1-infected patients. Methods: Five subjects treated with saquinavir and three with...
3.
Koks C, van Heeswijk R, Veldkamp A, Meenhorst P, Mulder J, van der Meer J, et al.
AIDS
. 2000 Mar;
14(1):89-90.
PMID: 10714572
No abstract available.
4.
Verschraagen M, Koks C, Schellens J, Beijnen J
Pharmacol Res
. 1999 Oct;
40(4):301-6.
PMID: 10527640
Digoxin, which has a very narrow therapeutic window, is one of the most commonly prescribed drugs in the treatment of congestive heart failure. In some cases of atrial fibrillation digoxin...
5.
Bronner G, Koks C, Beijnen J
Ned Tijdschr Geneeskd
. 1999 Mar;
143(2):122.
PMID: 10086119
No abstract available.
6.
RAMCHARAN S, Meenhorst P, Otten J, Koks C, de Boer D, Maes R, et al.
J Toxicol Clin Toxicol
. 1998 Dec;
36(7):727-31.
PMID: 9865243
Introduction: The toxicity profile of the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") is well known. This designer drug is usually taken at "house parties" and may cause severe complications, sometimes leading...
7.
Huitema A, Soesan M, Meenhorst P, Koks C, Beijnen J
Hum Exp Toxicol
. 1998 Sep;
17(7):406-8.
PMID: 9726538
We report a case of a 29-year-old woman with a borderline personality disorder who presented with intentional substantial acetaminophen (paracetamol) overdosage on nine occasions during a period of 21 months....
8.
Hoetelmans R, Meenhorst P, Mulder J, Burger D, Koks C, Beijnen J
Pharm World Sci
. 1997 Aug;
19(4):159-75.
PMID: 9297727
In this review the clinical pharmacology of HIV protease inhibitors, a new class of antiretroviral drugs, is discussed. After considering HIV protease function and structure, the development of inhibitors of...
9.
Hoetelmans R, Kraaijeveld C, Meenhorst P, Mulder J, Burger D, Koks C, et al.
J Acquir Immune Defic Syndr Hum Retrovirol
. 1997 Jun;
15(2):131-6.
PMID: 9241112
The penetration of 3'-amino-3'-deoxythymidine (AMT) into the cerebrospinal fluid (CSF) of HIV-1-infected patients has been investigated. In 23 patients who used zidovudine (ZDV) chronically, CSF and plasma samples were assayed...
10.
Witterland A, Koks C, Beijnen J
Pharm World Sci
. 1996 Oct;
18(5):163-70.
PMID: 8933576
Etoposide (Vepesid) is a widely used drug in a variety of neoplasms. To improve the pharmaceutical characteristics of etoposide, etoposide phosphate (Etopophos, Bristol-Myers Squibb) has been developed as a prodrug....